Probiotics combined with rifaximin influence the neurometabolic changes in a rat model of type C HE

Abstract Type C hepatic encephalopathy (HE) is a neuropsychiatric disease caused by chronic liver disease. Management of type C HE remains an important challenge because treatment options are limited. Both the antibiotic rifaximin and probiotics have been reported to reduce the symptoms of HE, but l...

Full description

Saved in:
Bibliographic Details
Main Authors: Emmanuelle Flatt, Valérie A. McLin, Olivier Braissant, Katarzyna Pierzchala, Paola Mastromarino, Stefanita-Octavian Mitrea, Dario Sessa, Rolf Gruetter, Cristina Cudalbu
Format: article
Language:EN
Published: Nature Portfolio 2021
Subjects:
R
Q
Online Access:https://doaj.org/article/a7ef8e8b4f0c43e88d7e80c9cb740c5a
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items